Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Joshua Kushner Buys 358,619 Shares

Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Joshua Kushner acquired 358,619 shares of the company’s stock in a transaction dated Wednesday, November 13th. The shares were acquired at an average price of $13.74 per share, for a total transaction of $4,927,425.06. Following the completion of the purchase, the insider now owns 5,810,700 shares of the company’s stock, valued at approximately $79,839,018. This represents a 6.58 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Joshua Kushner also recently made the following trade(s):

• On Monday, November 11th, Joshua Kushner acquired 276,040 shares of Oscar Health stock. The shares were acquired at an average price of $13.58 per share, for a total transaction of $3,748,623.20.

Oscar Health Trading Up 14.6 %

NYSE OSCR opened at $15.45 on Friday. The company has a fifty day simple moving average of $18.28 and a two-hundred day simple moving average of $18.30. The stock has a market cap of $3.74 billion, a P/E ratio of -251.12, a P/E/G ratio of 12.49 and a beta of 1.67. Oscar Health, Inc. has a 12-month low of $6.93 and a 12-month high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. During the same period in the prior year, the business posted ($0.29) EPS. The company’s quarterly revenue was up 68.3% on a year-over-year basis. On average, analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Price T Rowe Associates Inc. MD grew its position in Oscar Health by 153.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after buying an additional 2,409,160 shares during the period. Westfield Capital Management Co. LP purchased a new position in Oscar Health during the third quarter worth about $27,452,000. First Light Asset Management LLC raised its stake in Oscar Health by 117.3% during the first quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after purchasing an additional 1,134,919 shares during the period. Renaissance Technologies LLC raised its stake in Oscar Health by 31.7% during the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after purchasing an additional 934,600 shares during the period. Finally, Point72 Asset Management L.P. purchased a new position in Oscar Health during the second quarter worth about $14,716,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. UBS Group assumed coverage on shares of Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective on the stock. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Finally, Piper Sandler reissued an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a research report on Tuesday, September 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.